Characterizing the use of botulinum toxin in patients with Hirschsprung disease treated at referral institutions for pediatric colorectal surgery.

[1]  J. Oosterlaan,et al.  Intrasphincteric botulinum toxin injections for post-operative obstructive defecation problems in hirschsprung disease: A retrospective observational study. , 2020, Journal of pediatric surgery.

[2]  O. Nafiu,et al.  Race, Postoperative Complications, and Death in Apparently Healthy Children , 2020, Pediatrics.

[3]  C. Di Lorenzo,et al.  Anal sphincter botulinum toxin injection in children with functional anorectal and colonic disorders: A large institutional study and review of the literature focusing on complications. , 2019, Journal of pediatric surgery.

[4]  J. Oosterlaan,et al.  Botulinum toxin injections after surgery for Hirschsprung disease: Systematic review and meta-analysis , 2019, World journal of gastroenterology.

[5]  R. Nataraja,et al.  Prevention and management of recurrent postoperative Hirschsprung's disease obstructive symptoms and enterocolitis: Systematic review and meta-analysis. , 2018, Journal of pediatric surgery.

[6]  M. Levitt,et al.  The Pediatric Colorectal and Pelvic Learning Consortium (PCPLC): rationale, infrastructure, and initial steps , 2018, Techniques in Coloproctology.

[7]  Oguz Akbilgic,et al.  Race, Preoperative Risk Factors, and Death After Surgery , 2018, Pediatrics.

[8]  R. Radhakrishnan,et al.  Race and outcomes in gastroschisis repair: a nationwide analysis. , 2017, Journal of pediatric surgery.

[9]  D. Rothstein,et al.  Guidelines for the management of postoperative obstructive symptoms in children with Hirschsprung disease , 2017, Pediatric Surgery International.

[10]  B. Chumpitazi,et al.  Defecation Disorders in Children After Surgery for Hirschsprung Disease , 2011, Journal of pediatric gastroenterology and nutrition.

[11]  A. Nasr,et al.  Intrasphincteric botulinum toxin decreases the rate of hospitalization for postoperative obstructive symptoms in children with Hirschsprung disease. , 2011, Journal of pediatric surgery.

[12]  M. Levitt,et al.  Evaluation and treatment of the patient with Hirschsprung disease who is not doing well after a pull-through procedure. , 2010, Seminars in pediatric surgery.

[13]  M. Pakarinen,et al.  Botox injection treatment for anal outlet obstruction in patients with internal anal sphincter achalasia and Hirschsprung’s disease , 2009, Pediatric Surgery International.

[14]  J. Langer,et al.  Evaluation and management of persistent problems after surgery for Hirschsprung disease in a child. , 2008, Journal of pediatric gastroenterology and nutrition.

[15]  J. Langer,et al.  Preliminary experience with intrasphincteric botulinum toxin for persistent constipation after pull-through for Hirschsprung's disease. , 1997, Journal of pediatric surgery.